These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37625154)

  • 21. Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?
    Giri S; Sundaram S
    Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):724. PubMed ID: 35481849
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis.
    Amonker S; Houshmand A; Hinkson A; Rowe I; Parker R
    Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37102767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative alcohol cessation intervention for postoperative complications.
    Egholm JW; Pedersen B; Møller AM; Adami J; Juhl CB; Tønnesen H
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008343. PubMed ID: 30408162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol Relapse After Early Liver Transplantation in Patients With Alcoholic Liver Disease: A Meta-Analysis.
    Zafar Y; Siddiqi AK; Shaikh N; Imran M; Javaid SS; Manzoor L; Iqbal AZ; Petrasek J
    Gastroenterology Res; 2024 Feb; 17(1):10-14. PubMed ID: 38463145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of alcohol dependence in patients with liver disease.
    Addolorato G; Mirijello A; Leggio L; Ferrulli A; Landolfi R
    CNS Drugs; 2013 Apr; 27(4):287-99. PubMed ID: 23456576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addiction Consult Service and Inpatient Outcomes Among Patients with Alcohol Use Disorder.
    Singh-Tan S; Torres-Lockhart K; Jakubowski A; Lu T; Starrels J; De Lima P; Arnsten J; Nahvi S; Southern W
    J Gen Intern Med; 2023 Nov; 38(14):3216-3223. PubMed ID: 37100986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence.
    Mosoni C; Dionisi T; Vassallo GA; Mirijello A; Tarli C; Antonelli M; Sestito L; Rando MM; Tosoni A; De Cosmo S; Gasbarrini A; Addolorato G
    Front Psychiatry; 2018; 9():474. PubMed ID: 30327620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to 'acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?'.
    Tyson LD; Lewis H
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):976. PubMed ID: 35913782
    [No Abstract]   [Full Text] [Related]  

  • 29. The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis.
    Donoghue K; Elzerbi C; Saunders R; Whittington C; Pilling S; Drummond C
    Addiction; 2015 Jun; 110(6):920-30. PubMed ID: 25664494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes After Initiation of Medications for Alcohol Use Disorder at Hospital Discharge.
    Bernstein EY; Baggett TP; Trivedi S; Herzig SJ; Anderson TS
    JAMA Netw Open; 2024 Mar; 7(3):e243387. PubMed ID: 38551564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of abstinence in patients undergoing liver transplantation for alcoholic liver disease.
    Altamirano J; Bataller R; Cardenas A; Michelena J; Freixa N; Monrás M; Ríos J; Liccioni A; Caballería J; Gual A; Lligoña A
    Ann Hepatol; 2012; 11(2):213-21. PubMed ID: 22345338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.
    Gudan A; Jamioł-Milc D; Hawryłkowicz V; Skonieczna-Żydecka K; Stachowska E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication prescribing for alcohol use disorders during alcohol-related encounters in a Colorado regional healthcare system.
    Chockalingam L; Burnham EL; Jolley SE
    Alcohol Clin Exp Res; 2022 Jun; 46(6):1094-1102. PubMed ID: 35723682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence.
    Punia K; Scott W; Manuja K; Sabbineni M; Campbell K; Balodis IM; MacKillop J
    Acad Emerg Med; 2024 May; 31(5):504-514. PubMed ID: 37735346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.
    McPheeters M; O'Connor EA; Riley S; Kennedy SM; Voisin C; Kuznacic K; Coffey CP; Edlund MD; Bobashev G; Jonas DE
    JAMA; 2023 Nov; 330(17):1653-1665. PubMed ID: 37934220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.
    Pavlov CS; Casazza G; Semenistaia M; Nikolova D; Tsochatzis E; Liusina E; Ivashkin VT; Gluud C
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011602. PubMed ID: 26934429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.
    Barrault C; Lison H; Roudot-Thoraval F; Garioud A; Costentin C; Béhar V; Medmoun M; Pulwermacher G; Hagège H; Cadranel JF
    Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1155-1160. PubMed ID: 28727631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of alcohol reduction pharmacotherapy according to treatment duration in patients with alcohol dependence or alcohol use disorder: A systematic review and network meta-analysis.
    Kotake K; Hosokawa T; Tanaka M; So R; Banno M; Kataoka Y; Shiroshita A; Hashimoto Y
    Addiction; 2024 May; 119(5):815-832. PubMed ID: 38173342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.